Table 2.
Effects of DPP4i on the incidence, number, and volume of HCCs
| Control group | DPP4i group | p | |
|---|---|---|---|
| Incidence of HCC | 100% (8/8) | 87.5% (7/8) | ns |
| Number of HCCs | 4.5±1.7/liver | 1.8±1.2/liver | <0.01 |
| Volume of HCCs | 37.5±72.5 mm3/liver | 11.2±20.8 mm3/liver | <0.05 |
Data are expressed as mean ± SD. Differences between the two groups were analyzed using the Wilcoxon rank-sum test.p values<0.05 were considered significant. HCC, hepatocellular carcinoma; DPP4i, dipeptidyl peptidase-4 inhibitor; ns, not significant.